What does workers' compensation — total IBNR mean?

This represents the total estimated liability for claims that have been incurred but not yet reported to the insurer for the workers' compensation segment. It is a critical actuarial reserve component used to ensure the company maintains sufficient capital to cover future claim obligations. High levels of IBNR relative to premiums may indicate potential volatility in future loss development.

King Pharmaceuticals KG Workers' Compensation — Total IBNR

Other product segments

General Liability

4,098,200,000%—

European Hospital Liability

1,391,000,000%—

Commercial Auto Liability

715,500,000%—

All other lines

551,000,000%—

International

313,500,000%—

Similar metrics at other companies

SIGIWorkers Compensation — IBNR

$124.79M+15.6%

CNAWorkers' Compensation — IBNR

118,200,000,000%-3,400,000,000pp

HIGWorkers' Compensation — IBNR Reserves

$1.56B+1.8%

AIGU.S. Workers' Compensation (before discount) — Total of IBNR Liabilities Plus Expected Development on Reported Losses

$484M+6.4%

ORIWorkers' Compensation — Total of Incurred-but-Not-Reported Liabilities Plus Expected Development on Reported Losses

$254.4M-7.2%

WRBWorkers' compensation — Short-duration insurance contracts, incurred but not reported (IBNR) claims liability, net

$350.18M-7.4%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — total ibnr.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — total IBNR?: King Pharmaceuticals (KG) reported workers' compensation — total IBNR of 13,266,800,000% in Q4 2025.
What does workers' compensation — total IBNR mean?: This represents the total estimated liability for claims that have been incurred but not yet reported to the insurer for the workers' compensation segment. It is a critical actuarial reserve component used to ensure the company maintains sufficient capital to cover future claim obligations. High levels of IBNR relative to premiums may indicate potential volatility in future loss development.